Sensitive Blood Test CAN HELP Rule Out CORONARY ATTACK: – WEDNESDAY, Oct bitartrate . 7, 2015 – – A new, highly sensitive blood test can help doctors quickly eliminate heart attack for nearly two-thirds of people who seek er treatment for chest pain, a new study suggests. Researchers said their results could reduce unnecessary hospital admissions and substantially lower health-care costs potentially. Until now, there have been no quick ways to rule away a coronary attack within the emergency division, said the study’s business lead writer, Dr. Anoop Shah, from the University of Edinburgh in Scotland. Over the last two decades, the true number of hospital admissions due to chest pain has tripled.

In fact, without exception, the remission, relapse, and survival end factors in both groups were equivalent. Although multiple cycles of high-dose cytarabine have commonly been applied, accumulated evidence is consistent with the idea that administering a single cycle of high-dose cytarabine for induction or consolidation therapy is enough and produces maximal antileukemic effects. Pharmacokinetic studies of cytarabine concentrations in the plasma and the accumulation of its energetic 5-triphosphate metabolite in the leukemic cells have suggested that dose degrees of cytarabine at 3000 mg per square meter are much above saturating concentrations .21 The dose-level issue is relevant because high-dosage cytarabine is associated with life-threatening toxic results clinically.5,9,10 Therefore, the use of high-dose cytarabine is normally avoided in patients 60 years or older.